A leading commercial-stage precision health company focused on democratizing high-quality care globally through the use of our proprietary digital technologies that enable healthcare providers to provide better care for patients. Our software products combine expertise in image formation, magnetic resonance (MR) image analysis and artificial intelligence (AI) to support healthcare provider diagnosis, treatment decision-making and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy.
Lead Underwriter
Barclays Capital Inc, Canaccord Genuity LLC, Citigroup Global Markets Inc, Stifel Nicolaus & Company, Incorporated
